Molecular Brain Research 1998-01-01

Inhibition of lysophosphatidic acid-induced neurite retraction and cell rounding by SR 57746A.

M Magazin, P Schiltz, J L Zachayus, E Cavrois, D Caput, P Ferrara

Index: Brain Res. Mol. Brain Res. 53(1-2) , 301-6, (1998)

Full Text: HTML

Abstract

Rapid neurite retraction and transient rounding of serum-starved NG108-15 and PC12 cells by lysophosphatidic acid (LPA) is retarded and reduced by pre-incubation of the cells with the small non-peptidic molecule, SR 57746A, which exhibits neurotrophic properties. The compound also antagonizes the redistribution of filamentous actin by LPA in both cell types. We hypothesize that the SR 57746A attenuation of LPA-induced effects may account for at least some of the neuroprotective properties of this molecule.

Related Compounds

Related Articles:

5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.

2009-09-01

[Br. J. Pharmacol. 158(1) , 232-42, (2009)]

Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.

2002-06-01

[Invest. Radiol. 37(6) , 321-7, (2002)]

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

1999-10-26

[Proc. Natl. Acad. Sci. U. S. A. 96(22) , 12855-9, (1999)]

SR57746A: a survival factor for motor neurons in vivo.

1998-10-01

[J. Neurol. Sci. 160 Suppl 1 , S92-6, (1998)]

Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound.

1996-08-02

[Neurosci. Lett. 213(2) , 79-82, (1996)]

More Articles...